Table of Contents

1 Report Overview
1.1 Global Bio-MEMS & Microfluidics Overview
1.2 Research Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.3 Market Evaluation & Forecasting Methodology
1.4 Global Bio-MEMS & Microfluidics Market Segmentation
1.5 Overview of Findings
1.6 Why You Should Read This Report
1.7 How this report delivers?
1.8 Key Questions Answered by This Analytical Report
1.9 Frequently Asked Questions (FAQ)
1.10 Who is This Report For?

2 Introduction to Bio-MEMS & Microfluidics
2.1 Applications of Bio-MEMS & Microfluidics
2.1.1 Therapeutics
2.1.2 Diagnostics
2.1.3 Tissue Engineering

3 Global Bio-MEMS & Microfluidics Market Forecast to 2027

4 Global Bio-MEMS & Microfluidics Market by Type: Market Forecast to 2027
4.1 Overview
4.2 Implantable Bio-MEMS & Microfluidics
4.2.1 Biosensors
4.2.2 Gyroscopes
4.2.3 Stents
4.2.4 Drug Delivery Devices
4.2.5 Biochips
4.2.6 Accelerometers
4.3 Injectable Bio-MEMS & Microfluidics
4.3.1 Microneedles
4.3.2 Micromodules
4.4 Others Devices Bio-MEMS & Microfluidics
4.4.1 Inhalers
4.4.2 Catheters
4.4.3 Micro motors

5 Global Bio-MEMS & Microfluidics Market by Application: Market Forecast to 2027
5.1 Overview
5.2 Diagnostic
5.3 Therapeutics
5.4 Tissue Engineering
5.5 Others

6 Global Bio-MEMS & Microfluidics Market by End-User: Market Forecast to 2027
6.1 Overview
6.2 Pharmaceutical Industry
6.3 Hospitals
6.4 Research Centres
6.5 Other Applications

7 Regional Bio-MEMS & Microfluidics Market Forecasts to 2027
7.1 Regional Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.2 North American Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.2.1 USA Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.2.2 Canada Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.2.3 Mexico Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3 South American Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.1 Brazil Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.2 Argentina Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.3 Paraguay Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.4 Bolivia Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.3.5 Rest of South America Bio-MEMS & Microfluidics Market Forecast 2016-2027
7.4 European Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.1 France Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.2 Germany Bio-MEMS & Microfluidics Market Forecast 2016-2027
7.4.3 UK Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.4 Spain Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.5 Italy Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.4.6 Rest of Europe Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5 Asia-Pacific Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.1 China Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.2 Japan Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.3 India Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.4 Australia Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.5 Thailand Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.5.6 Rest of Asia-Pacific Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.6 Rest of World Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.6.1 Middle East Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.6.2 Africa Bio-MEMS & Microfluidics Market Forecast 2017-2027
7.6.3 Other Countries Bio-MEMS & Microfluidics Market Forecast 2017-2027

8. Bio-MEMS & Microfluidics Market, Qualitative Analysis, 2017-2027
8.1 Porter’s Five Forces Analysis
8.1.1 Bargaining Power of Buyers (High)
8.1.2 Bargaining Power of Suppliers (Medium)
8.1.3 Threat of New Entrants (Medium)
8.1.4 Threat of Substitute Products (High)
8.1.5 Intensity of Competitive Rivalry (High)
8.2 Drivers & Restrains
8.2.1 Application of Bio-MEMS in drug delivery
8.2.2 Increase in geriatric population and surge in incidence and prevalence of chronic diseases
8.2.3 Increase in government expenditure in the healthcare sector
8.2.4 Complex regulatory framework
8.2.5 Lucrative opportunities from emerging economies

9 Leading Companies in Bio-MEMS & Microfluidics Market
9.1 Abbott Diagnostics (A Business Division Abbott Laboratories Inc.)
9.1.1 Abbott Diagnostics: Company Overview
9.1.2 Abbott Diagnostics: Product Portfolio
9.1.3 Abbott Diagnostics: Recent Developments
9.2 Nova Biomedical
9.2.1 Nova Biomedical: Company Overview
9.2.2 Nova Biomedical: Product Portfolio
9.2.3 Nova Biomedical: Recent Developments
9.3 Danaher Corporation (Pall ForteBio)
9.3.1 Danaher Corporation: Company Overview
9.3.2 Danaher Corporation: Product Portfolio
9.3.3 Danaher Corporation: Recent Developments
9.4 Thermo Fisher Scientific Inc. (Affymetrix)
9.4.1 Thermo Fisher Scientific Inc.: Company Overview
9.4.2 Thermo Fisher Scientific Inc.: Product Portfolio
9.4.3 Thermo Fisher Scientific Inc.: Recent Developments
9.5 Fraunhofer-IMS
9.5.1 Fraunhofer-IMS: Company Overview
9.5.2 Fraunhofer-IMS: Product Portfolio
9.6 Medtronic PLC
9.6.1 Medtronic PLC: Company Overview
9.6.2 Medtronic PLC: Product Portfolio
9.6.3 Medtronic PLC: Recent Developments
9.7 Boston Scientific Corporation
9.7.1 Boston Scientific Corporation: Company Overview
9.7.2 Boston Scientific Corporation: Product Portfolio
9.7.3 Boston Scientific Corporation: Recent Developments
9.8 F. HOFFMANN-LA ROCHE AG
9.8.1 F. Hoffmann-La Roche: Company Overview
9.8.2 F. Hoffmann-La Roche: Product Portfolio
9.8.3 F. Hoffmann-La Roche: Recent Developments
9.9 Johnson & Johnson
9.9.1 Johnson & Johnson: Company Overview
9.9.2 Johnson & Johnson: Product Portfolio
9.9.3 Johnson & Johnson: Recent Developments
9.10 Becton, Dickinson and Company
9.10.1 Becton, Dickinson and Company: Company Overview
9.10.2 Becton, Dickinson and Company: Product Portfolio
9.10.3 Becton, Dickinson and Company: Recent Developments

10 Conclusions
10.1 Current Leading Segments
10.2 Leading Regional Markets
10.3 Emerging Markets
10.4 The Future of the Market?